CURIS, INC. Derivative Liability, Noncurrent
CURIS, INC. (CRIS) had Derivative Liability, Noncurrent of $3.81 million as of 2012-03-31, per its 10-Q filed 2012-05-10.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DerivativeLiabilitiesNoncurrent · last filed 2012-05-10
- 2012-03-31: Derivative Liability, Noncurrent $3.81M.
- 2011-12-31: Derivative Liability, Noncurrent $4.36M.
- 2011-09-30: Derivative Liability, Noncurrent $2.84M.
- 2010-12-31: Derivative Liability, Noncurrent $1.60M.
| Period end | Derivative Liability, Noncurrent |
|---|---|
| 2012-03-31 | $3.81M 10-Q · filed 2012-05-10 |
| 2011-12-31 | $4.36M 10-Q · filed 2012-05-10 |
| 2011-09-30 | $2.84M 10-Q · filed 2011-10-31 |
| 2010-12-31 | $1.60M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |